 Geigy later became Ciba-Geigy and eventually Novartis.Dibenzazepine derivatives are described in U.S. patent 3,074,931 issued 1963-01-22 by assignment to Smith Kline & French Laboratories.The compounds described share a tricyclic backbone different from the backbone of the TCA amitriptyline.